Analystreport

Health Catalyst (NASDAQ: HCAT) had its price target raised by analysts at Guggenheim from $33.00 to $37.00.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report